SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

The Revenue for the quarter ended  September 2022 of Rs. 13794.80 millions grew by 12.88 % from Rs. 12220.60 millions.A good growth in profit of 38.05% reported to Rs. 2655.20  millions over Rs. 1923.30 millions of corresponding previous quarter.The company reported a good operating profit of 3768.30 millions compared to 2779.00 millions of corresponding previous quarter.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202209 202109 % Var 202209 202109 % Var 202203 202103 % Var
Sales 13794.80 12220.60 12.88 26838.50 24398.90 10.00 49192.70 43100.20 14.14
Other Income 335.30 182.10 84.13 598.90 374.20 60.05 772.10 809.00 -4.56
PBIDT 3768.30 2779.00 35.60 6735.90 5622.60 19.80 11649.30 10023.60 16.22
Interest 39.70 45.10 -11.97 81.90 95.50 -14.24 191.00 182.80 4.49
PBDT 3728.60 2733.90 36.38 6654.00 5527.10 20.39 11458.30 9840.80 16.44
Depreciation 174.70 162.00 7.84 348.20 319.30 9.05 661.00 581.30 13.71
PBT 3553.90 2571.90 38.18 6305.80 5207.80 21.08 10797.30 9259.50 16.61
TAX 898.70 648.60 38.56 1594.20 1326.90 20.14 2810.30 2352.60 19.46
Deferred Tax -18.30 -41.60 -56.01 -30.50 -69.40 -56.05 41.80 -37.90 -210.29
PAT 2655.20 1923.30 38.05 4711.60 3880.90 21.40 7987.00 6906.90 15.64
Equity 212.50 212.50 0.00 212.50 212.50 0.00 212.50 212.50 0.00
PBIDTM(%) 27.32 22.74 20.13 25.10 23.04 8.91 23.68 23.26 1.82

Abbott India Share Price

26360.00 -118.60 (-0.45%)
11-Jun-2026 09:41 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1788.00
Dr. Reddys Lab 1276.20
Cipla 1380.90
Zydus Lifesciences 1103.85
Lupin 2259.00
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×